Article
Molecular Cancer Therapeutics  (2015)

Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications

Adelaiye, R.; Ciamporcero, E.; Miles, K. M.; Sotomayor, P.; Bard, J.; Tsompana, M.; Conroy, D.; Shen, L.; Ramakrishnan, S.; Ku, S.-Y.; Orillion, A.; Prey, J.; Fetterly, G.; Buck, M.; Chintala, S.; et. al.